glp-1 mast cell activation syndrome GLP-1s in MCAS with Dr. Tania Dempsey - Matters: Deep dives on MCAS with Tania Dempsey, MD - Presented by The POTScast Frontiers | The immunomodulatory effects

Valcheva P, Cardus A, Panizo S, Parisi E, Bozic M, Lopez Novoa JM, Dusso A, Fernndez E, Valdivielso JM (2014) Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals

Regarding the other ocular outcomes studied, our findings on visual disturbances and oculomotor binocular dysfunction further enhance the understanding of anti-obesity medications ocular profile

As Fillit noted, GLP-1 drugs would be very good candidates to be delivered in combination with an anti-amyloid drug like Eisai and Biogens recently approved Leqembi (lecanemab) or Lillys investigational donanemab, because there is no overlap in the mechanism of action

#104, Palm Desert, CA 92211 Mon-Fri: 9am - 5pm